Amgen Stock Affected by Shifts in Institutional Investor Holdings

Amgen Inc.'s (NASDAQ:AMGN) stock has been impacted by changes in its institutional investor holdings. CX Institutional, a fund, cut its stake in Amgen shares by 32% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission.

The fund owned 25,985 shares of Amgen's stock after selling 12,252 shares during the quarter. CX Institutional's holdings in Amgen were worth $9,410,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. Anfield Capital Management LLC lifted its stake in Amgen by 1,000% in the fourth quarter, while Dogwood Wealth Management LLC grew its position in Amgen by 275% during the same period.